Literature DB >> 23152610

Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

Renaud La Joie1, Audrey Perrotin, Louisa Barré, Caroline Hommet, Florence Mézenge, Méziane Ibazizene, Vincent Camus, Ahmed Abbas, Brigitte Landeau, Denis Guilloteau, Vincent de La Sayette, Francis Eustache, Béatrice Desgranges, Gaël Chételat.   

Abstract

Gray matter atrophy, glucose hypometabolism, and β-amyloid Aβ deposition are well-described hallmarks of Alzheimer's disease, but their relationships are poorly understood. The present study aims to compare the local levels of these three alterations in humans with Alzheimer's disease. Structural magnetic resonance imaging, (18)F-fluorodeoxyglucose positron emission tomography (PET), and (18)F-florbetapir PET data from 34 amyloid-negative healthy controls and 20 demented patients with a high probability of Alzheimer's disease etiology (attested using neuroimaging biomarkers as recently recommended) were analyzed. For each patient and imaging modality, age-adjusted Z-score maps were computed, and direct between-modality voxelwise comparison and correlation analyses were performed. Significant differences in the levels of atrophy, hypometabolism, and Aβ deposition were found in most brain areas, but the hierarchy differed across regions. A cluster analysis revealed distinct subsets of regions: (1) in the hippocampus, atrophy exceeded hypometabolism, whereas Aβ load was minimal; (2) in posterior association areas, Aβ deposition was predominant, together with high hypometabolism and lower but still significant atrophy; and (3) in frontal regions, Aβ deposition was maximal, whereas structural and metabolic alterations were low. Atrophy and hypometabolism significantly correlated in the hippocampus and temporo-parietal cortex, whereas Aβ load was not significantly related to either atrophy or hypometabolism. These findings provide direct evidence for regional variations in the hierarchy and relationships between Aβ load, hypometabolism, and atrophy. Altogether, these variations probably reflect the differential involvement of region-specific pathological or protective mechanisms, such as the presence of neurofibrillary tangles, disconnection, as well as compensation processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152610      PMCID: PMC6794030          DOI: 10.1523/JNEUROSCI.2170-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  51 in total

1.  The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia.

Authors:  Marina Boccardi; Mikko P Laakso; Lorena Bresciani; Samantha Galluzzi; Cristina Geroldi; Alberto Beltramello; Hilkka Soininen; Giovanni B Frisoni
Journal:  Neurobiol Aging       Date:  2003 Jan-Feb       Impact factor: 4.673

2.  Biological parametric mapping: A statistical toolbox for multimodality brain image analysis.

Authors:  Ramon Casanova; Ryali Srikanth; Aaron Baer; Paul J Laurienti; Jonathan H Burdette; Satoru Hayasaka; Lynn Flowers; Frank Wood; Joseph A Maldjian
Journal:  Neuroimage       Date:  2006-10-27       Impact factor: 6.556

3.  Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.

Authors:  Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

4.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.

Authors:  Christopher C Rowe; Kathryn A Ellis; Miroslava Rimajova; Pierrick Bourgeat; Kerryn E Pike; Gareth Jones; Jurgen Fripp; Henri Tochon-Danguy; Laurence Morandeau; Graeme O'Keefe; Roger Price; Parnesh Raniga; Peter Robins; Oscar Acosta; Nat Lenzo; Cassandra Szoeke; Olivier Salvado; Richard Head; Ralph Martins; Colin L Masters; David Ames; Victor L Villemagne
Journal:  Neurobiol Aging       Date:  2010-05-15       Impact factor: 4.673

Review 5.  Amyloid-dependent and amyloid-independent stages of Alzheimer disease.

Authors:  Bradley T Hyman
Journal:  Arch Neurol       Date:  2011-04-11

6.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y C Xu; S C Waring; P C O'Brien; E G Tangalos; G E Smith; R J Ivnik; E Kokmen
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

7.  Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.

Authors:  Adam S Fleisher; Kewei Chen; Xiaofen Liu; Auttawut Roontiva; Pradeep Thiyyagura; Napatkamon Ayutyanont; Abhinay D Joshi; Christopher M Clark; Mark A Mintun; Michael J Pontecorvo; P Murali Doraiswamy; Keith A Johnson; Daniel M Skovronsky; Eric M Reiman
Journal:  Arch Neurol       Date:  2011-07-11

8.  Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia.

Authors:  Michael Ewers; Reisa A Sperling; William E Klunk; Michael W Weiner; Harald Hampel
Journal:  Trends Neurosci       Date:  2011-06-21       Impact factor: 13.837

9.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease.

Authors:  T Gómez-Isla; R Hollister; H West; S Mui; J H Growdon; R C Petersen; J E Parisi; B T Hyman
Journal:  Ann Neurol       Date:  1997-01       Impact factor: 10.422

Review 10.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

View more
  157 in total

1.  Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.

Authors:  Miguel Ángel Araque Caballero; Matthias Brendel; Andreas Delker; Jinyi Ren; Axel Rominger; Peter Bartenstein; Martin Dichgans; Michael W Weiner; Michael Ewers
Journal:  Neurobiol Aging       Date:  2015-08-18       Impact factor: 4.673

2.  Direct voxel-based comparisons between grey matter shrinkage and glucose hypometabolism in chronic alcoholism.

Authors:  Ludivine Ritz; Shailendra Segobin; Coralie Lannuzel; Céline Boudehent; François Vabret; Francis Eustache; Hélène Beaunieux; Anne L Pitel
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

Review 3.  FDG-PET Contributions to the Pathophysiology of Memory Impairment.

Authors:  Shailendra Segobin; Renaud La Joie; Ludivine Ritz; Hélène Beaunieux; Béatrice Desgranges; Gaël Chételat; Anne Lise Pitel; Francis Eustache
Journal:  Neuropsychol Rev       Date:  2015-08-30       Impact factor: 7.444

4.  A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease.

Authors:  Anna C van Loenhoud; Alle Meije Wink; Colin Groot; Sander C J Verfaillie; Jos Twisk; Frederik Barkhof; Bart van Berckel; Philip Scheltens; Wiesje M van der Flier; Rik Ossenkoppele
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

5.  White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.

Authors:  Yongxia Zhou; Fang Yu; Timothy Q Duong
Journal:  J Magn Reson Imaging       Date:  2013-12-31       Impact factor: 4.813

6.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

Authors:  Stefan Teipel; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Bernd Krause; Michel Grothe
Journal:  Neurobiol Aging       Date:  2013-10-28       Impact factor: 4.673

7.  Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.

Authors:  Gaël Chételat; Rik Ossenkoppele; Victor L Villemagne; Audrey Perrotin; Brigitte Landeau; Florence Mézenge; William J Jagust; Vincent Dore; Bruce L Miller; Stéphanie Egret; William W Seeley; Wiesje M van der Flier; Renaud La Joie; David Ames; Bart N M van Berckel; Philip Scheltens; Frederik Barkhof; Christopher C Rowe; Colin L Masters; Vincent de La Sayette; Femke Bouwman; Gil D Rabinovici
Journal:  Brain       Date:  2016-06-29       Impact factor: 13.501

8.  Deep sparse multi-task learning for feature selection in Alzheimer's disease diagnosis.

Authors:  Heung-Il Suk; Seong-Whan Lee; Dinggang Shen
Journal:  Brain Struct Funct       Date:  2015-05-21       Impact factor: 3.270

Review 9.  Neuroimaging Abnormalities in Neurological Patients with Criminal Behavior.

Authors:  R Ryan Darby
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-14       Impact factor: 5.081

10.  Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer's disease patients and healthy subjects.

Authors:  Federico Nemmi; Laure Saint-Aubert; Djilali Adel; Anne-Sophie Salabert; Jérémie Pariente; Emmanuel J Barbeau; Pierre Payoux; Patrice Péran
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.